The next phase of real-world clinical experience with alefacept: the AWARE-2 registry

J Cutan Med Surg. 2009 Dec;13 Suppl 3:S148-52. doi: 10.2310/7750.2009.00033.
No abstract available

Publication types

  • Clinical Trial, Phase IV
  • Comparative Study
  • Multicenter Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alefacept
  • Canada / epidemiology
  • Dermatologic Agents / administration & dosage*
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Follow-Up Studies
  • Humans
  • Injections, Intramuscular
  • Morbidity / trends
  • Prospective Studies
  • Psoriasis / drug therapy*
  • Recombinant Fusion Proteins / administration & dosage*
  • Registries*
  • Treatment Outcome

Substances

  • Dermatologic Agents
  • Recombinant Fusion Proteins
  • Alefacept